<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03361605</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00103361</org_study_id>
    <nct_id>NCT03361605</nct_id>
  </id_info>
  <brief_title>Neuroimaging of Anesthetic Modulation of Human Consciousness</brief_title>
  <official_title>Neuroimaging of Anesthetic Modulation of Human Consciousness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study's purpose is to see if mental functions take place during different levels of&#xD;
      anesthesia, using a commonly used drug (Propofol). fMRI (functional Magnetic Resonance&#xD;
      Imaging, or &quot;brain imaging&quot;) shows areas in the brain involved in thinking at different&#xD;
      depths of anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Administering anesthetic drugs to suppress consciousness is an imperatively important step in&#xD;
      major surgical operations. Yet the neurobiological mechanisms that underlie loss of&#xD;
      consciousness under general anesthesia remain elusive. Despite advancements in understanding&#xD;
      the molecular, synaptic, and cellular effects of anesthetics, the large-scale, systems-level&#xD;
      modulation of neuronal processes that support conscious cognitive functions is incompletely&#xD;
      understood. While profound decreases in global and regional brain metabolism, blood flow, and&#xD;
      functional connectivity have been reported, these changes often fail to correlate with the&#xD;
      loss and return of consciousness. To date, there is no &quot;consciousness meter&quot; or &quot;gold&#xD;
      standard&quot; to objectively assess and monitor the level of consciousness under general&#xD;
      anesthesia. Several studies suggest that residual cognitive functions may not completely&#xD;
      vanish under general anesthesia; however, the level and complexity of residual information&#xD;
      processing in the anesthetized brain remains unknown. Finally, the neurobiological mechanisms&#xD;
      that govern anesthesia induction and emergence appear to be partially different, but the&#xD;
      relevance of these differences to the modulation of the state of consciousness is unclear.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 12, 2017</start_date>
  <completion_date type="Actual">July 12, 2019</completion_date>
  <primary_completion_date type="Actual">July 12, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Blood Oxygen Level Dependent (BOLD) Response to Sensory Stimuli During Sedation</measure>
    <time_frame>Baseline to 90 minutes</time_frame>
    <description>Change = BOLD Response During Sedation - BOLD Response During Baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Squeeze Pressure</measure>
    <time_frame>Baseline to 90 minutes</time_frame>
    <description>Measurements of the force of participants' hand squeezing on a rubber ball in response to instructions. Change = Squeeze Pressure During Sedation - Squeeze Pressure During Baseline.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Propofol Administration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol administration</description>
    <arm_group_label>Propofol Administration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Must have a body mass index (BMI) less than 30.&#xD;
&#xD;
          2. Must be right handed&#xD;
&#xD;
          3. Must be English speaking&#xD;
&#xD;
          4. Must be capable of giving written informed consent.&#xD;
&#xD;
          5. Must have history of playing tennis (or any type of racquet sport) at least 30 times&#xD;
             over lifetime.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of obstructive sleep apnea;&#xD;
&#xD;
          2. History of a difficult airway with a previous anesthetic;&#xD;
&#xD;
          3. History of neurological disorders;&#xD;
&#xD;
          4. Hypertension or other cardiovascular abnormalities;&#xD;
&#xD;
          5. Pulmonary hypertension or other pulmonary abnormalities;&#xD;
&#xD;
          6. Gastroesophageal reflux disease (GERD) or heartburn;&#xD;
&#xD;
          7. History of significant head injury with loss of consciousness;&#xD;
&#xD;
          8. Learning disability or other developmental disorder;&#xD;
&#xD;
          9. Allergic reactions to eggs;&#xD;
&#xD;
         10. Pregnant or nursing mothers;&#xD;
&#xD;
         11. Contraindications to neuroimaging methods;&#xD;
&#xD;
         12. Inability or unwilling to fast, or withhold food and liquid intake, for 8 hours prior&#xD;
             to your scheduled study visit.&#xD;
&#xD;
         13. Unwilling to abstain from alcohol use for 24 hours prior to your scheduled study&#xD;
             visit.&#xD;
&#xD;
         14. History of drug use, or have a positive drug screen.&#xD;
&#xD;
         15. Tattoos on the head or neck region - all other tattoos are subject to determination by&#xD;
             investigators.&#xD;
&#xD;
         16. Any impairment, activity or situation that in the judgment of the study coordinator or&#xD;
             Principal Investigators would prevent satisfactory completion of the study protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony G Hudetz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Michigan Medicine - University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>November 3, 2017</study_first_submitted>
  <study_first_submitted_qc>November 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2017</study_first_posted>
  <results_first_submitted>June 25, 2020</results_first_submitted>
  <results_first_submitted_qc>July 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 5, 2020</results_first_posted>
  <last_update_submitted>August 4, 2020</last_update_submitted>
  <last_update_submitted_qc>August 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Anthony G Hudetz</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 10, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/05/NCT03361605/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Propofol Administration</title>
          <description>Propofol: Propofol administration</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Analyzable data not available</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>29 participants were consented and received study drug.</population>
      <group_list>
        <group group_id="B1">
          <title>Propofol Administration</title>
          <description>Propofol: Propofol administration</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BOLD response</title>
          <description>The BOLD (blood oxygen level-dependent) signal is the measured variable as obtained by functional magnetic resonance imaging (fMRI). It is an indirect, relative measure of local neuronal activity in the brain. Higher BOLD signal value indicates more neuronal activity.</description>
          <population>Analyzable data was not available for four subjects</population>
          <units>percentage of BOLD signal change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.599" spread="0.244"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Squeeze pressure</title>
          <population>Analyzable data was not available for four subjects</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.98" spread="5.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Blood Oxygen Level Dependent (BOLD) Response to Sensory Stimuli During Sedation</title>
        <description>Change = BOLD Response During Sedation - BOLD Response During Baseline</description>
        <time_frame>Baseline to 90 minutes</time_frame>
        <population>Intent to study brain activity change (BOLD response) during propofol administration</population>
        <group_list>
          <group group_id="O1">
            <title>Propofol Administration</title>
            <description>Propofol: Propofol administration</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Blood Oxygen Level Dependent (BOLD) Response to Sensory Stimuli During Sedation</title>
          <description>Change = BOLD Response During Sedation - BOLD Response During Baseline</description>
          <population>Intent to study brain activity change (BOLD response) during propofol administration</population>
          <units>percentage of BOLD signal change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.349" spread="0.223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis is no difference in BOLD response between sedated state and baseline.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Our study adopted a within-subject design, which is not a randomized controlled trial (RCT) such as testing if one treatment is superior to another. Therefore, here the &quot;Superiority&quot; indicates if propofol administration has a statistically significant impact on the brain activity in response to sensory stimuli.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>The threshold for statistical significance was p=0.05. The p-value was not adjusted for multiple comparisons, as only one comparison was performed.</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.349</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.223</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>Difference = BOLD Response During Sedation - BOLD Response During Baseline</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Squeeze Pressure</title>
        <description>Measurements of the force of participants' hand squeezing on a rubber ball in response to instructions. Change = Squeeze Pressure During Sedation - Squeeze Pressure During Baseline.</description>
        <time_frame>Baseline to 90 minutes</time_frame>
        <population>Intent to study squeeze pressure change during propofol administration</population>
        <group_list>
          <group group_id="O1">
            <title>Propofol Administration</title>
            <description>Propofol: Propofol administration</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Squeeze Pressure</title>
          <description>Measurements of the force of participants' hand squeezing on a rubber ball in response to instructions. Change = Squeeze Pressure During Sedation - Squeeze Pressure During Baseline.</description>
          <population>Intent to study squeeze pressure change during propofol administration</population>
          <units>Millimeter of mercury (mmHg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.16" spread="3.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis is no difference in squeeze pressure between sedated state and baseline.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Our study adopted a within-subject design, which is not a randomized controlled trial (RCT) such as testing if one treatment is superior to another. Therefore, here the &quot;Superiority&quot; indicates if propofol administration has a statistically significant impact on the squeeze pressure in response to verbal instructions.</non_inferiority_desc>
            <p_value>0.00148</p_value>
            <p_value_desc>The threshold for statistical significance was p=0.05. The p-value was not adjusted for multiple comparisons, as only one comparison was performed.</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-2.16</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.09</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>Difference = Squeeze Pressure During Sedation - Squeeze Pressure During Baseline</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Propofol Administration</title>
          <description>Propofol: Propofol administration</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Amy McKinney</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734-647-8129</phone>
      <email>adrongo@med.umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

